Testing Laboratories - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Testing industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Testing Laboratories - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Testing Laboratories
Corporate Insider Buy Sell Ratio (Insider Count) - Testing Laboratories
Testing Laboratories - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date		 Security Form Insider Code 10b5-1 Direct Share
Price		 Shares
Changed
2020-03-25 DIGP / Hypha Labs, Inc. 4 Peterson Todd A A - Award D 0.10 500,000
2020-03-19 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 8.0819 -30,774
2020-03-19 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 1.25 0
2020-03-13 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund M - Exercise I -125,000
2020-03-13 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund M - Exercise I 4.78 125,000
2020-03-11 DIGP / Hypha Labs, Inc. 4 Remenda Kyle A - Award D 2,925,000
2020-03-09 DIGP / Hypha Labs, Inc. 4 Remenda Kyle A - Award D 750,000
2020-03-09 DIGP / Hypha Labs, Inc. 4 RABEN BRUCE I A - Award D 1,000,000
2020-03-04 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D -96,167
2020-03-04 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D 8.03 96,167
2020-03-04 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. S - Sale D 30.86 -98,093
2020-03-02 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER A - Award D 28.33 15,006
2020-03-02 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER A - Award D 2,330
2020-03-02 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B A - Award D 5,824
2020-03-02 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B A - Award D 28.33 37,514
2020-03-02 NEO / NeoGenomics, Inc. 4 VAN OORT DOUGLAS M A - Award D 34,945
2020-03-02 NEO / NeoGenomics, Inc. 4 VAN OORT DOUGLAS M A - Award D 28.33 225,084
2020-03-02 NEO / NeoGenomics, Inc. 4 Bonello William A - Award D 28.33 37,514
2020-03-02 NEO / NeoGenomics, Inc. 4 Bonello William A - Award D 5,824
2020-03-02 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin A - Award D 28.33 37,514
2020-03-02 NEO / NeoGenomics, Inc. 4 Weiss Lawrence Martin A - Award D 5,824
2020-03-02 NEO / NeoGenomics, Inc. 4 Pedulla Denise E A - Award D 28.33 18,757
2020-03-02 NEO / NeoGenomics, Inc. 4 Pedulla Denise E A - Award D 2,912
2020-03-02 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. A - Award D 28.33 56,271
2020-03-02 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. A - Award D 8,736
2020-03-02 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE A - Award D 28.33 48,768
2020-03-02 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE A - Award D 7,571
2020-03-02 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund S - Sale I 28.85 -250,000
2020-03-02 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By self as Trustee for Steven and Carisa Jones 401k and Trust S - Sale I 28.48 -25,000
2020-03-02 NEO / NeoGenomics, Inc. 4 JONES STEVEN C Shares owned in IRA, custodian accounts, and trusts for the family of Steven Jones S - Sale I 28.24 -2,300
2020-03-02 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Jones Network, LP S - Sale I 28.24 -20,000
2020-03-01 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER F - Taxes D -212
2020-03-01 NEO / NeoGenomics, Inc. 4 VAN OORT DOUGLAS M F - Taxes D -2,353
2020-03-01 NEO / NeoGenomics, Inc. 4 McKenzie Kathryn B F - Taxes D -168
2020-03-01 NEO / NeoGenomics, Inc. 4 Bonello William F - Taxes D -499
2020-03-01 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. F - Taxes D -810
2020-01-31 DIGP / Hypha Labs, Inc. 4 Hartmann Dennis A - Award D 250,000
2020-01-31 DIGP / Hypha Labs, Inc. 4 DeFrank Edmond A - Award D 250,000
2020-01-02 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L A - Award D 20,786
2019-12-30 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund M - Exercise I 4.78 100,000
2019-12-30 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund M - Exercise I -100,000
2019-12-30 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund J - Other I 100,000
2019-12-30 NEO / NeoGenomics, Inc. 4 JONES STEVEN C J - Other D -100,000
2019-12-30 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund J - Other I 225,000
2019-12-30 NEO / NeoGenomics, Inc. 4 JONES STEVEN C J - Other D -225,000
2019-12-25 DIGP / Hypha Labs, Inc. 4 Peterson Todd A A - Award D 171,233
2019-12-12 APDN / Applied DNA Sciences, Inc. 4 Anchin Scott L A - Award D 20,834
2019-12-12 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 1.2136 22,000
2019-12-11 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 1.2 1,000
2019-12-11 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)